Question 1

How many shares of IKT does Bank of New York Mellon Corp own?

Accepted Answer

As of 2026-Q2, Bank of New York Mellon Corp holds 303,126 shares of IKT (INHIBIKASE THERAPEUTICS INC).

Question 2

What is Bank of New York Mellon Corp's IKT position worth?

Accepted Answer

As of 2026-Q2, Bank of New York Mellon Corp's IKT position is worth $615,346.

Question 3

Is Bank of New York Mellon Corp buying or selling IKT?

Accepted Answer

In 2026-Q2, Bank of New York Mellon Corp increased their IKT position (+42.2% change in shares).

Question 4

When did Bank of New York Mellon Corp first buy IKT?

Accepted Answer

Based on available 13F filings, Bank of New York Mellon Corp first reported a position in IKT in 2025-Q2. They have held the position across 5 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	303,126	+42.2%	$615,346	0.0%	$2.03	33
2026-Q1	Increased	213,208	+55.1%	$358,189	0.0%	$1.91	33
2025-Q4	Decreased	137,485	-0.8%	$281,844	0.0%	$1.97	0
2025-Q3	Increased	138,667	+4.7%	$224,641	0.0%	$1.53	16
2025-Q2	New	132,473	-	$258,322	0.0%	$1.62	36

IKT5 quarters

IKT
5 quarters